Clinical Trial Update: Oral Colchicine in Argentina to Prevent Restenosis [Phase 4]

View source ↗

Summary

A Phase 4 trial in Argentina tested whether oral colchicine can prevent restenosis after coronary artery stenting. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Coronary Syndrome
• Restenosis of Coronary Artery Stent

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Centro de estudios en Cardiologia Intervencionista | Conditions: Coronary Artery Disease, Restenosis of Coronary Artery Stent | Phase 4 | Status: COMPLETED